Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades.
INTRODUCTION: Treatment-related death (TRD) remains a serious problem in small-cell lung cancer (SCLC), despite recent improvements in supportive care. However, few studies have formally assessed time trends in the proportion of TRD over the past two decades. The aim of this study was to determine t...
Main Authors: | Nobuaki Ochi, Katsuyuki Hotta, Nagio Takigawa, Isao Oze, Yoshiro Fujiwara, Eiki Ichihara, Akiko Hisamoto, Masahiro Tabata, Mitsune Tanimoto, Katsuyuki Kiura |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3412813?pdf=render |
Similar Items
-
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.
by: Katsuyuki Hotta, et al.
Published: (2011-01-01) -
Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results.
by: Isao Oze, et al.
Published: (2009-01-01) -
Rapid on-site evaluation with BIOEVALUATOR® during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing pulmonary and mediastinal diseases
by: Daisuke Minami, et al.
Published: (2014-01-01) -
Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer
by: Hideko Isozaki, et al.
Published: (2015-04-01) -
The Role of STAT3 in Non-Small Cell Lung Cancer
by: Daijiro Harada, et al.
Published: (2014-03-01)